Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 60382101000001117 | Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 60382201000001112 | Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) | Is a | Aztreonam 75mg powder and solvent for nebuliser solution vials | false | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) | Has active ingredient | Aztreonam | false | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) | Has specific active ingredient | Aztreonam lysine | false | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) | Has dispensed dose form | Powder and solvent for nebuliser solution | false | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Aztreonam | false | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) | Is a | Cayston | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences Ltd) 84 vial | Has AMP | False | Cayston 75mg powder and solvent for nebuliser solution vials (Gilead Sciences International Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR